Aesthetic Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 31-05-2024
- Paid Up Capital ₹ 0.10 M
as on 31-05-2024
- Company Age 7 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.00 M
as on 31-05-2024
- Revenue 82.54%
(FY 2022)
- Profit 2570.68%
(FY 2022)
- Ebitda 44.01%
(FY 2022)
- Net Worth 25.28%
(FY 2022)
- Total Assets -0.11%
(FY 2022)
About Aesthetic Lifesciences
The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.00 M.
Soni Gupta, Tara Kushwaha, Ram Mourya, and One other member serve as directors at the Company.
- CIN/LLPIN
U51909UP2017PTC092629
- Company No.
092629
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 Apr 2017
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Bareilly, Uttar Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Aesthetic Lifesciences?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Soni Gupta  | Director | 01-Nov-2019 | Current |
| Tara Kushwaha | Director | 26-Apr-2017 | Current |
| Ram Mourya | Director | 26-Apr-2017 | Current |
| Dinesh Maurya | Director | 26-Apr-2017 | Current |
Financial Performance of Aesthetic Lifesciences.
Aesthetic Lifesciences Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 82.54% increase. The company also saw a substantial improvement in profitability, with a 2570.68% increase in profit. The company's net worth Soared by an impressive increase of 25.28%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Aesthetic Lifesciences?
Unlock access to Aesthetic Lifesciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 22 Sep 2022 | ₹1.00 M | Open |
How Many Employees Work at Aesthetic Lifesciences?
Unlock and access historical data on people associated with Aesthetic Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Aesthetic Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aesthetic Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
